Cargando…
Profile of minocycline and its potential in the treatment of schizophrenia
Accumulating evidence suggests that neuroinflammation affecting microglia plays an important role in the etiology of schizophrenia, and appropriate control of microglial activation may be a promising therapeutic strategy for schizophrenia. Minocycline, a second-generation tetracycline that inhibits...
Autores principales: | Zhang, Lulu, Zhao, Jingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069141/ https://www.ncbi.nlm.nih.gov/pubmed/24971013 http://dx.doi.org/10.2147/NDT.S64236 |
Ejemplares similares
-
Minocycline as adjunct therapy for a male patient with deficit schizophrenia
por: Chen, Xiaohua, et al.
Publicado: (2018) -
Use of minocycline in viral infections
por: Dutta, Kallol, et al.
Publicado: (2011) -
Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013) -
Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia
por: Giovanoli, S, et al.
Publicado: (2016) -
The therapeutic role of minocycline in Parkinson’s disease
por: Cankaya, Seyda, et al.
Publicado: (2019)